Buy $TLRY - NRPicks 14 MarTilray, Inc. is dedicated to the research, cultivation, processing and distribution of medical cannabis. The company offers its products to patients, doctors, clinics, pharmacies, governments and hospitals.
The Ministry of Health and the New Zealand Medicinal Cannabis Agency grant Tilray the first approval under the new Medicinal Cannabis Plan to launch medicinal cannabis products across the country, which will undoubtedly have a major impact on revenue of the company.
During the week, most sectors showed a recovery, however, the marijuana companies had a controlled upside and this is likely to continue. We consider that Tilray is in the middle of its journey.
Technical:
- Average RSI levels
- Buying force 143M buying volume last week.
- Bounce on MA100
TLRY trade ideas
$TLRY Bounce looks impulsiveI am anticipating a retest of upper resistance, most likely pre-market. Waves 5 can extend, but it wouldn't be reasonable not to expect at least some sort of pull back before charging higher.
Breaking the .618 at $28.85 would be the first hint that we could see a try at $29.50.
Tilray (TLRY) : Marijuana is comingDue to Marijuana is going to accept in a lot of country
Tilray is one of big company which have Marijuana product & their product is expanding & export to other country
Please monitor business growth of this company
Stock graph is continue rebound after USA government accept to stimulus package
Currently stock graph's trend is going up